SAA-1, a major acute-phase reactant elevated in prolonged inflammatory conditions and previously described as a sepsis biomarker [25], was significantly upregulated in sepsis in comparison to HLH and healthy donors. Here, SAA1 is linked to hemophagocytic syndrome.